Department of Surgery, Guthrie-Robert Packer Hospital, One Guthrie Square, Sayre, PA 18840, USA.
Surg Clin North Am. 2010 Apr;90(2):377-98. doi: 10.1016/j.suc.2009.12.008.
Intraductal papillary mucinous neoplasm (IPMN) is an intraductal mucin-producing epithelial neoplasm that arises from the main pancreatic duct (MD-IPMN), secondary branch ducts (BD-IPMN), or both (mixed type; Mix-IPMN). Neoplastic progression from benign adenoma to invasive adenocarcinoma has not been proven but is generally thought to occur. With increasing recognition of IPMN, our understanding of the diagnosis and management of the tumors is evolving. At present, treatment options for patients with IPMN range from observation to pancreatic resection depending on the natural history of the lesion. This review focuses on currently available data that guide management decisions for patients with IPMN.
导管内乳头状黏液性肿瘤(IPMN)是一种来源于主胰管(MD-IPMN)、次级分支胰管(BD-IPMN)或两者(混合型;Mix-IPMN)的产生黏蛋白的导管内上皮性肿瘤。从良性腺瘤到浸润性腺癌的肿瘤进展尚未得到证实,但一般认为会发生。随着对 IPMN 的认识不断提高,我们对这些肿瘤的诊断和治疗的理解也在不断发展。目前,根据病变的自然史,IPMN 患者的治疗选择范围从观察到胰腺切除术不等。本综述重点介绍了目前可用于指导 IPMN 患者管理决策的现有数据。